Alemtuzumab (Campath-1H) Monoclonal Antibody in Patients With Relapsed and Resistant Classical Hodgkin's Disease
Clinical trial NCT00129753 · WITHDRAWN
Trial details
- NCT number
- NCT00129753
- Sponsor
- M.D. Anderson Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-22
- Primary completion
- 2006-09-05
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.